Phase I trial of fixed dose rate infusion (FDRI) gemcitabine (GEM) with gefitinib in patients with advanced pancreatic carcinoma.

被引：0
|
作者：
Carneiro, B [1 ]
Brand, R [1 ]
Fine, E [1 ]
Knop, R [1 ]
Khandekar, J [1 ]
Uhlig, W [1 ]
Locker, GY [1 ]
机构：
[1] Evanston NW Healthcare, Evanston, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：337S / 337S
页数：1
相关论文
共 50 条
  • [1] Phase I trial of fixed dose rate infusion gemcitabine with gefitinib in patients with pancreatic carcinoma
    Carneiro, Benedito A.
    Brand, Randall E.
    Fine, Elita
    Knop, Richard H.
    Khandekar, Janardan D.
    Uhlig, William
    Locker, Gershon Y.
    CANCER INVESTIGATION, 2007, 25 (05) : 366 - 371
  • [2] Phase I trial of gefitinib with concurrent radiotherapy and fixed dose-rate gemcitabine infusion, in locally advanced pancreatic cancer.
    Maurel, J.
    Martin-Richard, M.
    Conill, C.
    Sanchez, M.
    Petriz, L.
    Ginés, A.
    Gallego, R.
    Cajal, R.
    Navarro, S.
    Fernandez-Cruz, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 204S - 204S
  • [3] Fixed dose-rate gemcitabine (GEM) infusion in advanced pancreatic (PDAC) and biliary tree (BTC) carcinoma: A phase II study
    Gelibter, A
    Di Cosimo, S
    Ruggeri, EM
    Carlini, P
    Bria, E
    Malaguti, P
    Pellicciotta, M
    Terzoli, E
    Cognetti, F
    Milella, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 358S - 358S
  • [4] Phase I study of fixed dose rate infusion of gemcitabine in patients with unresectable pancreatic cancer
    Furuse, J
    Ishii, H
    Okusaka, T
    Nagase, M
    Nakachi, K
    Ueno, H
    Ikeda, M
    Morizane, C
    Yoshino, M
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (12) : 733 - 738
  • [5] Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic carcinoma
    Espinosa, E.
    Feliu, J.
    de Castro, J.
    Belda, C.
    Casado, E.
    Herrero, A.
    Sereno, M.
    Pinto, A.
    Gomez, C.
    Baron, M. Gonzalez
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-H gemcitabine infusion, in locally advanced pancreatic cancer
    Maurel, Joan
    Martin-Richard, Marta
    Conill, Carlos
    Sanchez, Marcelo
    Petriz, Lourdes
    Gines, Angels
    Miquel, Rosa
    Gallego, Rosa
    Cajal, Rosana
    Ayuso, Carmen
    Navarro, Salvador
    Marmol, Maribel
    Nadal, Cristina
    Auge, Josep Maria
    Fernandez-Cruz, Laureano
    Gascon, Pere
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (05): : 1391 - 1398
  • [7] A phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma
    Eng, C
    Ramathan, RK
    Wong, MK
    Remick, SC
    Dai, L
    Wade-Oliver, KT
    Mani, S
    Kindler, HL
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (06): : 565 - 569
  • [8] A phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma. (vol 27, pg 565, 2004)
    Eng, C
    Ramanathan, RK
    Wong, MK
    Remick, SC
    Dai, L
    Wade-Oliver, KT
    Mani, S
    Kindler, HL
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (05): : 455 - 455
  • [9] Fixed-dose-rate gemcitabine infusion in patients with advanced pancreatic or biliary tree adenocarcinoma
    Mane, Joan M.
    Sancho, Aintzane
    Munoz, Alberto
    Rubio, Itziar
    Fernandez, Ricardo
    Carrera, Sergio
    Fuente, Natalia
    Ballesteros, David
    Casas, Raquel
    Marrodan, Ines
    Mielgo, Xabier
    Lopez-Vivanco, Guillermo
    TUMORI, 2010, 96 (03) : 405 - 410
  • [10] A phase I trial of fixed-dose-rate (FDR) gemcitabine and irinotecan combination in patients with advanced pancreatic and biliary cancer.
    Sun, W
    Theobald, ME
    Hershock, D
    Haller, DG
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 341S - 341S
12345